“Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi-institutional propensity score matched study”—Authors' reply
Umberto Bracale
Department of Public Health, University of Naples Federico II, Naples, Italy
Search for more papers by this authorCorresponding Author
Roberto Peltrini
Department of Public Health, University of Naples Federico II, Naples, Italy
Correspondence Roberto Peltrini, Department of Public Health, School of Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy.
Email: [email protected]
Search for more papers by this authorFrancesco Corcione
Department of Public Health, University of Naples Federico II, Naples, Italy
Search for more papers by this authorUmberto Bracale
Department of Public Health, University of Naples Federico II, Naples, Italy
Search for more papers by this authorCorresponding Author
Roberto Peltrini
Department of Public Health, University of Naples Federico II, Naples, Italy
Correspondence Roberto Peltrini, Department of Public Health, School of Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy.
Email: [email protected]
Search for more papers by this authorFrancesco Corcione
Department of Public Health, University of Naples Federico II, Naples, Italy
Search for more papers by this author
REFERENCES
- 1Graziosi L, Marino E, Donini A. Reply to: “Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: a multi-institutional propensity score matched study”. J Surg Oncol. 2022; 125(3): 545.
- 2Bracale U, Corcione F, Pignata G, et al. Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: a multi-institutional propensity score-matched study. J Surg Oncol. 2021; 124(8): 1338-1346. doi:10.1002/jso.26657
- 3Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006; 355(1): 11-20.
- 4Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011; 29(13): 1715-1721.
- 5 Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021; 24(1): 1-21.
- 6 Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean practice guideline for gastric cancer 2018: an evidence-based, multi-disciplinary Approach. J Gastric Cancer. 2019; 19(1): 1-48.
- 7Agnes A, Biondi A, Laurino A, et al. A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer. J Surg Oncol. 2020; 122(2): 293-305.
- 8Marino E, Graziosi L, Donini A. Neoadjuvant chemotherapy for locally advanced gastric cancer: where we stand; an Italian single center perspective. In Vivo. 2021; 35(6): 3459-3466.
- 9Bracale U, Merola G, Pignata G, et al. Laparoscopic gastrectomy for stage II and III advanced gastric cancer: long-term follow-up data from a Western multicenter retrospective study. Surg Endosc. 2021. doi:10.1007/s00464-021-08505-y
